The Pfizer Clinical Research Unit in New Haven is seeking healthy Japanese volunteers for a clinical trial of a study drug for type 2 diabetes. This study will look at the effects of the study drug when taken as an oral suspension and with or without food.
Type 2 diabetes (T2D) is a chronic disease that occurs when a person’s body does not make or use insulin effectively to regulate blood sugar. Rates of T2D have been increasing in Japan over the last several years, and despite the availability of multiple treatments, approximately half of people diagnosed with T2D are not at their blood sugar goal. Pfizer aims to identify and develop breakthrough treatments for people with this disease.
Read more about this study below and see how you can make a difference as a healthy volunteer.
Who may participate
Clinical trials are the key to developing potential life-changing treatments for people across the globe, and at the center of all clinical trials are the participants that make them possible.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Must have 4 biological Japanese grandparents born in Japan
*participants may be eligible to receive a bonus for travel, ask our staff for details
**females must be unable to bear children
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Up to $200
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 18 overnights. Starting the morning after admission, you will receive a single dose of the study drug or placebo as a suspension (a liquid) to swallow once a week, up to 3 total doses. You may receive this with or without food. There are about 6 days between each dose.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
Required overnight stays
18 consecutive overnights
Long-term follow up
1 visit; 1 phone call
How long is this study?
About 44 days
Up to $6,660 upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.